nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—SCN5A—Riluzole—amyotrophic lateral sclerosis	0.593	0.812	CbGbCtD
Ropivacaine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.138	0.188	CbGbCtD
Ropivacaine—SCN3A—spinal nerve—amyotrophic lateral sclerosis	0.0171	0.193	CbGeAlD
Ropivacaine—SCN8A—peripheral nervous system—amyotrophic lateral sclerosis	0.00693	0.0782	CbGeAlD
Ropivacaine—SCN8A—nerve—amyotrophic lateral sclerosis	0.0054	0.061	CbGeAlD
Ropivacaine—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.00534	0.0296	CcSEcCtD
Ropivacaine—CNS depression NOS—Riluzole—amyotrophic lateral sclerosis	0.00485	0.0269	CcSEcCtD
Ropivacaine—SCN10A—peripheral nervous system—amyotrophic lateral sclerosis	0.00464	0.0523	CbGeAlD
Ropivacaine—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.00425	0.0235	CcSEcCtD
Ropivacaine—SCN8A—hindbrain—amyotrophic lateral sclerosis	0.00405	0.0457	CbGeAlD
Ropivacaine—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.004	0.0222	CcSEcCtD
Ropivacaine—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.004	0.0222	CcSEcCtD
Ropivacaine—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00395	0.0219	CcSEcCtD
Ropivacaine—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.00379	0.021	CcSEcCtD
Ropivacaine—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00364	0.0202	CcSEcCtD
Ropivacaine—SCN10A—nerve—amyotrophic lateral sclerosis	0.00362	0.0408	CbGeAlD
Ropivacaine—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.0036	0.0199	CcSEcCtD
Ropivacaine—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.00355	0.0197	CcSEcCtD
Ropivacaine—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.00355	0.0197	CcSEcCtD
Ropivacaine—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.00339	0.0188	CcSEcCtD
Ropivacaine—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00331	0.0183	CcSEcCtD
Ropivacaine—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00313	0.0174	CcSEcCtD
Ropivacaine—SCN1A—hindbrain—amyotrophic lateral sclerosis	0.00306	0.0345	CbGeAlD
Ropivacaine—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00295	0.0163	CcSEcCtD
Ropivacaine—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00289	0.016	CcSEcCtD
Ropivacaine—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00281	0.0156	CcSEcCtD
Ropivacaine—SCN2A—hindbrain—amyotrophic lateral sclerosis	0.00281	0.0317	CbGeAlD
Ropivacaine—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00267	0.0148	CcSEcCtD
Ropivacaine—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.00264	0.0147	CcSEcCtD
Ropivacaine—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.00264	0.0147	CcSEcCtD
Ropivacaine—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.0026	0.0144	CcSEcCtD
Ropivacaine—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0026	0.0144	CcSEcCtD
Ropivacaine—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00235	0.013	CcSEcCtD
Ropivacaine—SCN8A—brainstem—amyotrophic lateral sclerosis	0.00232	0.0262	CbGeAlD
Ropivacaine—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0117	CcSEcCtD
Ropivacaine—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00211	0.0117	CcSEcCtD
Ropivacaine—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00203	0.0112	CcSEcCtD
Ropivacaine—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00199	0.011	CcSEcCtD
Ropivacaine—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00199	0.011	CcSEcCtD
Ropivacaine—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00199	0.011	CcSEcCtD
Ropivacaine—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00198	0.011	CcSEcCtD
Ropivacaine—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00192	0.0107	CcSEcCtD
Ropivacaine—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00192	0.0107	CcSEcCtD
Ropivacaine—Coma—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0101	CcSEcCtD
Ropivacaine—SCN1A—brainstem—amyotrophic lateral sclerosis	0.00175	0.0198	CbGeAlD
Ropivacaine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0093	CcSEcCtD
Ropivacaine—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00921	CcSEcCtD
Ropivacaine—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00916	CcSEcCtD
Ropivacaine—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00895	CcSEcCtD
Ropivacaine—SCN2A—brainstem—amyotrophic lateral sclerosis	0.00161	0.0182	CbGeAlD
Ropivacaine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00852	CcSEcCtD
Ropivacaine—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00845	CcSEcCtD
Ropivacaine—Purpura—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00831	CcSEcCtD
Ropivacaine—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00828	CcSEcCtD
Ropivacaine—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00801	CcSEcCtD
Ropivacaine—SCN8A—spinal cord—amyotrophic lateral sclerosis	0.00144	0.0163	CbGeAlD
Ropivacaine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00788	CcSEcCtD
Ropivacaine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00762	CcSEcCtD
Ropivacaine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00762	CcSEcCtD
Ropivacaine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00759	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00732	CcSEcCtD
Ropivacaine—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00729	CcSEcCtD
Ropivacaine—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00724	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00721	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00706	CcSEcCtD
Ropivacaine—SCN9A—spinal cord—amyotrophic lateral sclerosis	0.00127	0.0143	CbGeAlD
Ropivacaine—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00697	CcSEcCtD
Ropivacaine—SCN1A—medulla oblongata—amyotrophic lateral sclerosis	0.00122	0.0138	CbGeAlD
Ropivacaine—SCN8A—nervous system—amyotrophic lateral sclerosis	0.00122	0.0137	CbGeAlD
Ropivacaine—SCN8A—central nervous system—amyotrophic lateral sclerosis	0.00117	0.0132	CbGeAlD
Ropivacaine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00647	CcSEcCtD
Ropivacaine—SCN8A—cerebellum—amyotrophic lateral sclerosis	0.00114	0.0129	CbGeAlD
Ropivacaine—SCN2A—medulla oblongata—amyotrophic lateral sclerosis	0.00112	0.0127	CbGeAlD
Ropivacaine—Depression—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00615	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00608	CcSEcCtD
Ropivacaine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00605	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00605	CcSEcCtD
Ropivacaine—SCN1A—spinal cord—amyotrophic lateral sclerosis	0.00109	0.0123	CbGeAlD
Ropivacaine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00602	CcSEcCtD
Ropivacaine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00108	0.006	CcSEcCtD
Ropivacaine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00588	CcSEcCtD
Ropivacaine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00564	CcSEcCtD
Ropivacaine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.001	0.00555	CcSEcCtD
Ropivacaine—SCN2A—spinal cord—amyotrophic lateral sclerosis	0.001	0.0113	CbGeAlD
Ropivacaine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000995	0.00551	CcSEcCtD
Ropivacaine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000995	0.00551	CcSEcCtD
Ropivacaine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000987	0.00547	CcSEcCtD
Ropivacaine—SCN3A—medulla oblongata—amyotrophic lateral sclerosis	0.000987	0.0111	CbGeAlD
Ropivacaine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000985	0.00546	CcSEcCtD
Ropivacaine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00098	0.00543	CcSEcCtD
Ropivacaine—SCN10A—spinal cord—amyotrophic lateral sclerosis	0.000965	0.0109	CbGeAlD
Ropivacaine—SCN4A—nervous system—amyotrophic lateral sclerosis	0.000953	0.0108	CbGeAlD
Ropivacaine—SCN8A—brain—amyotrophic lateral sclerosis	0.000929	0.0105	CbGeAlD
Ropivacaine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000928	0.00514	CcSEcCtD
Ropivacaine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000923	0.0104	CbGeAlD
Ropivacaine—SCN1A—nervous system—amyotrophic lateral sclerosis	0.000919	0.0104	CbGeAlD
Ropivacaine—SCN4A—central nervous system—amyotrophic lateral sclerosis	0.000918	0.0104	CbGeAlD
Ropivacaine—Chills—Riluzole—amyotrophic lateral sclerosis	0.000897	0.00497	CcSEcCtD
Ropivacaine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000893	0.00495	CcSEcCtD
Ropivacaine—SCN1A—central nervous system—amyotrophic lateral sclerosis	0.000885	0.00998	CbGeAlD
Ropivacaine—SCN3A—spinal cord—amyotrophic lateral sclerosis	0.00088	0.00993	CbGeAlD
Ropivacaine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000876	0.00485	CcSEcCtD
Ropivacaine—SCN1A—cerebellum—amyotrophic lateral sclerosis	0.000865	0.00976	CbGeAlD
Ropivacaine—Tension—Riluzole—amyotrophic lateral sclerosis	0.000854	0.00473	CcSEcCtD
Ropivacaine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000845	0.00468	CcSEcCtD
Ropivacaine—SCN2A—nervous system—amyotrophic lateral sclerosis	0.000843	0.00952	CbGeAlD
Ropivacaine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000842	0.00467	CcSEcCtD
Ropivacaine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000837	0.00464	CcSEcCtD
Ropivacaine—SCN9A—brain—amyotrophic lateral sclerosis	0.000817	0.00921	CbGeAlD
Ropivacaine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000815	0.00452	CcSEcCtD
Ropivacaine—SCN10A—nervous system—amyotrophic lateral sclerosis	0.000813	0.00918	CbGeAlD
Ropivacaine—SCN2A—central nervous system—amyotrophic lateral sclerosis	0.000812	0.00916	CbGeAlD
Ropivacaine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000808	0.00448	CcSEcCtD
Ropivacaine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000804	0.00446	CcSEcCtD
Ropivacaine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.0008	0.00443	CcSEcCtD
Ropivacaine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000795	0.00441	CcSEcCtD
Ropivacaine—SCN2A—cerebellum—amyotrophic lateral sclerosis	0.000794	0.00896	CbGeAlD
Ropivacaine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000785	0.00435	CcSEcCtD
Ropivacaine—SCN10A—central nervous system—amyotrophic lateral sclerosis	0.000783	0.00884	CbGeAlD
Ropivacaine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000782	0.00433	CcSEcCtD
Ropivacaine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000781	0.00433	CcSEcCtD
Ropivacaine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000765	0.00424	CcSEcCtD
Ropivacaine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00076	0.00421	CcSEcCtD
Ropivacaine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000754	0.00418	CcSEcCtD
Ropivacaine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000751	0.00416	CcSEcCtD
Ropivacaine—SCN3A—nervous system—amyotrophic lateral sclerosis	0.000741	0.00837	CbGeAlD
Ropivacaine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000741	0.00411	CcSEcCtD
Ropivacaine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000741	0.00411	CcSEcCtD
Ropivacaine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000741	0.00411	CcSEcCtD
Ropivacaine—SCN5A—nervous system—amyotrophic lateral sclerosis	0.000739	0.00834	CbGeAlD
Ropivacaine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000738	0.00409	CcSEcCtD
Ropivacaine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000732	0.00406	CcSEcCtD
Ropivacaine—SCN4A—brain—amyotrophic lateral sclerosis	0.000728	0.00822	CbGeAlD
Ropivacaine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000716	0.00397	CcSEcCtD
Ropivacaine—SCN3A—central nervous system—amyotrophic lateral sclerosis	0.000714	0.00805	CbGeAlD
Ropivacaine—SCN5A—central nervous system—amyotrophic lateral sclerosis	0.000712	0.00803	CbGeAlD
Ropivacaine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00071	0.00394	CcSEcCtD
Ropivacaine—Infection—Riluzole—amyotrophic lateral sclerosis	0.000706	0.00391	CcSEcCtD
Ropivacaine—SCN1A—brain—amyotrophic lateral sclerosis	0.000702	0.00793	CbGeAlD
Ropivacaine—Shock—Riluzole—amyotrophic lateral sclerosis	0.000699	0.00387	CcSEcCtD
Ropivacaine—SCN3A—cerebellum—amyotrophic lateral sclerosis	0.000698	0.00787	CbGeAlD
Ropivacaine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000696	0.00385	CcSEcCtD
Ropivacaine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000693	0.00384	CcSEcCtD
Ropivacaine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00069	0.00382	CcSEcCtD
Ropivacaine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000687	0.00381	CcSEcCtD
Ropivacaine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000664	0.00368	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000647	0.00359	CcSEcCtD
Ropivacaine—SCN2A—brain—amyotrophic lateral sclerosis	0.000645	0.00728	CbGeAlD
Ropivacaine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000643	0.00356	CcSEcCtD
Ropivacaine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000638	0.00353	CcSEcCtD
Ropivacaine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000633	0.00351	CcSEcCtD
Ropivacaine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000632	0.0035	CcSEcCtD
Ropivacaine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000625	0.00347	CcSEcCtD
Ropivacaine—SCN10A—brain—amyotrophic lateral sclerosis	0.000622	0.00702	CbGeAlD
Ropivacaine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000607	0.00337	CcSEcCtD
Ropivacaine—Pain—Riluzole—amyotrophic lateral sclerosis	0.000607	0.00337	CcSEcCtD
Ropivacaine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000585	0.00324	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000581	0.00322	CcSEcCtD
Ropivacaine—SCN3A—brain—amyotrophic lateral sclerosis	0.000567	0.00639	CbGeAlD
Ropivacaine—SCN5A—brain—amyotrophic lateral sclerosis	0.000565	0.00638	CbGeAlD
Ropivacaine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000564	0.00313	CcSEcCtD
Ropivacaine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000562	0.00311	CcSEcCtD
Ropivacaine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000562	0.00311	CcSEcCtD
Ropivacaine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000529	0.00597	CbGeAlD
Ropivacaine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000523	0.0029	CcSEcCtD
Ropivacaine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00051	0.00282	CcSEcCtD
Ropivacaine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000503	0.00279	CcSEcCtD
Ropivacaine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000486	0.00269	CcSEcCtD
Ropivacaine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00047	0.0026	CcSEcCtD
Ropivacaine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000452	0.0025	CcSEcCtD
Ropivacaine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000448	0.00248	CcSEcCtD
Ropivacaine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000447	0.00248	CcSEcCtD
Ropivacaine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000445	0.00247	CcSEcCtD
Ropivacaine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000422	0.00234	CcSEcCtD
Ropivacaine—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000373	0.00421	CbGeAlD
Ropivacaine—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000359	0.00405	CbGeAlD
Ropivacaine—CYP2B6—brain—amyotrophic lateral sclerosis	0.000285	0.00322	CbGeAlD
Ropivacaine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000282	0.00318	CbGeAlD
Ropivacaine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000277	0.00313	CbGeAlD
Ropivacaine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000271	0.00306	CbGeAlD
Ropivacaine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000267	0.00301	CbGeAlD
Ropivacaine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000261	0.00294	CbGeAlD
Ropivacaine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000212	0.00239	CbGeAlD
